{
    "SPADE_N_14409": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14409",
            "Peptide Name": "PMAP-23I (PMAP-23 T19I, synthetic AMPs, UCLL1)",
            "Source": "amino acid substitution, pig cathelicidin analog, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RIIDLLWRVRRPQKPKFVIVWVR",
            "Sequence Length": 23,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2974.64,
            "PI": 12.0,
            "Hydrophobicity": -0.07,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Liu Y, Shen T, Chen L, Zhou J, Wang C. 2021",
                    "Reference": "Probiotics Antimicrob Proteins. 2021 Feb;13(1):273-286. doi: 10.1007/s12602-020-09686-z.PubMed",
                    "Title": "Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity."
                }
            ],
            "Frequent Amino Acids": "RVI",
            "Absent Amino Acids": "ACEGHMNOSTUY",
            "Basic Residues": 7,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 14,
            "Polar Residues": 12,
            "Positive Residues": 7,
            "Negative Residues": 1,
            "Net Charge": 6,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (95.65%) toPMAP-23R: 22%, V: 17%, I: 13%.Activity: Active against S. aureus ATCC 25923 (MIC 0.025 ug/ml), S. epidermidis LY8 (MIC 25 ug/ml), L. monocytogenes CICC 21533 (MIC 125 ug/ml), B. subtilis CICC 24434 (MIC 1.56 ug/ml), S. enterica serovar Choleraesuis C78-1 or serovar Typhimurium SL1344 (MIC 0.78-1.56 ug/ml), P. multocida C48-3 (MIC 0.78 ug/ml), enterotoxigenic E. coli E44813 (MIC 12.5 ug/ml), and S. flexneri CICC 21534 (MIC 75 ug/ml).Antimicrobial robustness: Boiling 1-2 h slightly reduced peptide activity.In vitro toxicity: murine RBC: 4% hemolysis even at 1000 ug/ml, not hemo.lytic.Animal model:mouse: after daily treatment for 3 days, slightly protected mice from death due to S. aureus infection (IP).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22832",
                    "Similarity": 1.0,
                    "Sequence": "RIIDLLWRVRRPQKPKFVIVWVR"
                },
                {
                    "SPADE_ID": "SPADE_UN_25626",
                    "Similarity": 1.0,
                    "Sequence": "RIIDLLWRVRR"
                },
                {
                    "SPADE_ID": "SPADE_N_02561",
                    "Similarity": 0.9565217391304348,
                    "Sequence": "RIIDLLWRVRRPQKPKFVTVWVR"
                }
            ]
        }
    }
}